BLC
EHC icon

Brown, Lisle/Cummings’s Encompass Health EHC Stock Holding History

Brown, Lisle/Cummings’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$606 Sell
6
-1
-14% -$104 ﹤0.01% 1006
2026
Q1 		$677 Buy
+7
New +$718 ﹤0.01% 966

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Brown, Lisle/Cummings's EHC Position: Q2 2026 in Review

Brown, Lisle/Cummings reduced its Encompass Health (EHC) stake by 14% in Q2 2026, selling an estimated $104 and leaving 6 shares worth $606. The position accounts for ﹤0.01% of the portfolio, ranked #1006.

Brown, Lisle/Cummings first reported a position in EHC in Q1 2026 and has held it in 2 quarters since. The position peaked at $677 in Q1 2026. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Brown, Lisle/Cummings held 6 shares of Encompass Health worth $606 as of Q2 2026.
  • Brown, Lisle/Cummings sold 1 Encompass Health share in Q2 2026, an estimated $104.
  • Encompass Health made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #1006 holding.
  • Brown, Lisle/Cummings first reported a position in Encompass Health in Q1 2026 and has held it in 2 quarters since.
  • Brown, Lisle/Cummings's Encompass Health position peaked at $677 in Q1 2026.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.